Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros











Intervalo de año de publicación
1.
Biomed Mater ; 19(5)2024 Aug 13.
Artículo en Inglés | MEDLINE | ID: mdl-39094613

RESUMEN

The design of three-dimensional (3D) scaffolds should focus on creating highly porous, 3D structures with an interconnected pore network that supports cell growth. The scaffold's pore interconnectivity is directly linked to vascularization, cell seeding, guided cell migration, and transportation of nutrients and metabolic waste. In this study, different types of food flavors including monosodium glutamate, sugar, and sodium chloride were used as the porogens along with PCL/PVP blend polymer for solvent casting/particulate leaching method. The morphology, porosity, interconnectivity, chemical composition, water absorption, and mechanical properties of the fabricated scaffolds are carefully characterized. The scaffolds are biocompatible in bothin vitroandin vivoexperiments and do not trigger any inflammatory response while enhancing new bone formation and vascularization in rabbit calvaria critical-sized defects. The new bone merges and becomes denser along with the experiment timeline. The results indicate that the 3D PCL/PVP scaffolds, using monosodium glutamate as porogen, exhibited suitable biological performance and held promise for bone tissue engineering in oral and maxillofacial surgery.


Asunto(s)
Materiales Biocompatibles , Glutamato de Sodio , Solventes , Ingeniería de Tejidos , Andamios del Tejido , Animales , Andamios del Tejido/química , Conejos , Ingeniería de Tejidos/métodos , Porosidad , Solventes/química , Materiales Biocompatibles/química , Materiales Biocompatibles/farmacología , Poliésteres/química , Ensayo de Materiales , Cráneo/efectos de los fármacos , Polivinilos/química , Regeneración Ósea/efectos de los fármacos , Osteogénesis/efectos de los fármacos , Sustitutos de Huesos/química , Sustitutos de Huesos/farmacología , Huesos/metabolismo
2.
PLoS One ; 19(1): e0297187, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-38241315

RESUMEN

BACKGROUND: The Coronavirus disease of 2019 (COVID-19) pandemic and the corresponding mitigation measures have had a discernible impact on drug utilization among outpatients. However, limited research exists on the prescription trends in the elderly population during the pandemic period in Viet Nam. OBJECTIVES: This study aims to analyze the effects of COVID-19 on outpatient drug utilization patterns at a national geriatric hospital in Ho Chi Minh City before and after the early onset of the pandemic. METHODS: Data was collected from the prescriptions and administration claims, encompassing the period from January 2016 to December 2022. The dataset was divided into two periods: Period 1: January 2016 to December 2020 and Period 2: January 2021 to December 2022. The drug utilization was measured using DDD/1000P (defined daily doses-DDD per 1000 prescriptions) on a monthly basis. The analysis employed interrupted time series using Autoregressive Integrated Moving Average (ARIMA) to detect changes in drug use levels and rates. RESULTS: A total of 1,060,507 and 644,944 outpatient prescriptions from Thong Nhat Hospital were included in Period 1 and Period 2, respectively. The median age of the patients were 58 in Period 1 and 67 years old in Period 2. The most common comorbidities were dyslipidemia, hypertension, and diabetes mellitus. In terms of medication utilization, cardiovascular drugs were the most frequently prescribed, followed by drugs active on the digestive and hormonal systems. The study observed significant surges in the number of prescriptions and the average number of drugs per prescription. However, there were no significant changes in the overall consumption of all drugs. Among the drug groups related to the cardiovascular system, three subgroups experienced a sudden and significant increase: cardiac therapy, beta-blocking agents, and antihypertensives, with increasing consumption levels of 1,177.73 [CI 95%: 79.29; 2,276.16], 73.32 [CI 95%: 28.18; 118.46], and 36.70 [CI 95%: 6.74; 66.66] DDD/1000P, respectively. On the other hand, there was a significant monthly decrease of -31.36 [CI 95%: -57.02; -5.70] DDD/1000P in the consumption of anti-inflammatory and antirheumatic products. Interestingly, there was a significant increase of 74.62 [CI 95%: -0.36; 149.60] DDD/1000P in the use of antigout preparations. CONCLUSION: COVID-19 resulted in a sudden, non-significant increase in overall drug consumption levels among outpatients. Notably, our findings highlight significant increases in the utilization of three drug groups related to the cardiovascular system, specifically cardiac therapy, beta-blocking agents, and antihypertensives. Intriguingly, there was a statistically significant increase in the consumption of antigout preparations, despite a decline in the monthly consumption rate of non-steroidal anti-flammatory drugs (NSAIDs). Further studies in the following years are necessary to provide a more comprehensive understanding of the impact of COVID-19 on outpatient drug utilization patterns.


Asunto(s)
COVID-19 , Fármacos Cardiovasculares , Humanos , Anciano , Lactante , Preescolar , Niño , Adolescente , Adulto Joven , Adulto , Persona de Mediana Edad , Antihipertensivos/uso terapéutico , COVID-19/epidemiología , Utilización de Medicamentos , Fármacos Cardiovasculares/uso terapéutico , Diuréticos/uso terapéutico , Antagonistas Adrenérgicos beta/uso terapéutico , Prescripciones de Medicamentos
3.
Pract Lab Med ; 27: e00253, 2021 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-34458537

RESUMEN

INTRODUCTION: The external quality assessment (EQA) scheme is particularly important for laboratory performance evaluation. Peripheral blood smears are necessary to identify morphological features, and the procedure for preparing such smears must be robust to meet the ISO 15189 standard. Although blood smear preparation is a routine activity in medical laboratories, an appropriate procedure for preparing a series of blood smears with high homogeneity and durable stability for EQA purposes has not yet been published elsewhere. For this reason, a robust procedure was developed and validated in this study. METHODS: Various factors affecting blood smear preparation, such as the amount of time collected blood samples are stored before fixation, suitable reagents, and specification parameters for each step, including fixation, staining, and timing of the staining steps, were studied. Each experiment was evaluated based on homogeneity and stability characteristics. RESULTS: Whole blood mixed with EDTA anticoagulant was used to make the blood smears. Samples were fixed with pure anhydrous alcohol and stained in Coplin jars using the Wright-Giemsa method. CONCLUSION: The homogeneity and stability of two lots of smears suitable for EQA purposes was confirmed based on intact morphology of the smears for more than 8 months at room temperature.

4.
Artículo en Vietnamita | WPRIM (Pacífico Occidental) | ID: wpr-5128

RESUMEN

After myocardial infarction, there is a high mortality, patient needs a proper treatment. The medications include a group of antiagglutination of thrombocytes, anticoagulants, a group of beta receptor suppressor, a group of antimetabolism inhibitors, a group of calci channel suppressor, the medication of antiarrhythmia, treating blood lipid dysturbation. Supportive measures such as the change of living stype, stop smoking, proper diet and exercises were effective. Specially, it must treat activelyassociate factors such as diabetes, hypertension. Antioxidants such as vitamin A, vitamin E, folat, vitamin B and hormone therapy for menopause women are also helpful


Asunto(s)
Infarto del Miocardio , Pacientes , Mortalidad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA